PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $301,000 | -21.6% | 59,700 | 0.0% | 0.02% | -15.8% |
| Q2 2015 | $384,000 | -8.6% | 59,700 | 0.0% | 0.02% | -9.5% |
| Q1 2015 | $420,000 | -8.7% | 59,700 | 0.0% | 0.02% | -4.5% |
| Q4 2014 | $460,000 | +3.1% | 59,700 | 0.0% | 0.02% | +29.4% |
| Q3 2014 | $446,000 | -22.8% | 59,700 | 0.0% | 0.02% | -19.0% |
| Q2 2014 | $578,000 | +16.5% | 59,700 | 0.0% | 0.02% | +10.5% |
| Q1 2014 | $496,000 | – | 59,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |